한국어
English
日本語
中文(简体)
Fruza Clara Capsule 1 mg (Prucalopride)
1mg
Hard capsule · Prescription medication
Takeda Pharmaceutical Company Limited
Prucalopride is a component that exhibits anti-cancer effects by inhibiting the formation of blood vessels in cancer cells.
MFDS ingredient code M284500
Prucalopride is an anticancer agent that selectively inhibits the vascular endothelial growth factor receptor (VEGFR). It is primarily used to slow down the progression of cancer by blocking angiogenesis necessary for the growth of cancer cells.
Prucalopride binds to the vascular endothelial growth factor receptor and blocks its signaling. This prevents the formation of new blood vessels in tumor tissues, reducing the nutrient supply to cancer cells and inhibiting their growth.
Approved uses differ by product. Check each product's information for its actual use.
Prucalopride has a high selectivity for VEGFR and is specialized in angiogenesis inhibition, unlike other anticancer agents. This can reduce side effects as a targeted therapy and allow for effective anti-cancer action.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
